Search clinical trials for: Gonal-f® (follitropin alfa)

Total 637 results

Merckle GmbH

Completed

Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women

Bioequivalence
Ferring Pharmaceuticals

Completed

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in India Women (IRIS)

Infertility

India
Royan Institute

Unknown

Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism

Infertility

Iran, Islamic Republic of
IVFarma LLC
NADIM LLC

Completed

The Safety and Pharmacokinetics of Primapur and Gonal-f

Pharmacokinetics | Absorption | Area Under Curve

Russian Federation
Hangzhou YuYuan Bioscience Technology Co., Ltd.
LG Chem

Completed

Randomized Controlled Study of Comparing Follitrope Versus Gonal-f in Chinese Infertility Women.

Infertility, Female

China
Merck KGaA, Darmstadt, Germany

Completed

An Observational Study of Gonal-F Filled by Mass Pens in Multifollicular Stimulation Prior to In-vitro Fertilization (IVF) or Intracytoplasmic Sperm Injection (ICSI)

Multifollicular Stimulation

Korea, Republic of
IVFarma LLC
BridgePharm LLC; GlobalPharma LLC

Completed

Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment

Infertility, Female

Russian Federation
Merck KGaA, Darmstadt, Germany

Completed

CONSORT Randomized Controlled Trial in Assisted Reproductive Technology

Infertility

Switzerland
Ferring Pharmaceuticals

Recruiting

A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation (ADAPT-1)

Infertility

Italy, Spain, France, United Kingdom, Austria
Merck KGaA, Darmstadt, Germany

Completed

Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART) (ESPART)

Infertility

Germany
Fertility Biotech AG

Completed

Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

Infertility

United States
Fertility Biotech AG

Completed

Comparative Pharmacokinetics of AFOLIA and US Gonal-f® RFF Redi-ject After Single Subcutaneous Application

Healthy Volunteers

United Kingdom
Alphamab Jilin Co., Ltd.

Unknown

Study on the Safety and Pharmacokinetics of LM001 and Gonal-F® in Healthy Women

Infertility, Female
Gema Biotech S.A.
QUID Quality in Drugs and Devices Latin American Consulting SRL

Completed

A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART

Infertility

Argentina
Merck KGaA, Darmstadt, Germany
Merck Serono S.A.S, France

Terminated

EXpression PRofile Endometrium Samples Study (EXPRESS)

In Vitro Fertilization

France
Ferring Pharmaceuticals

Completed

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2 (ESTHER-2)

Infertility

Canada, Belgium, Brazil, Czechia, Denmark, France, Italy, Poland, Russian Federation, Spain, United Kingdom
Ferring Pharmaceuticals

Completed

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1 (ESTHER-1)

Infertility

Canada, Belgium, Brazil, Czechia, Denmark, France, Italy, Poland, Russian Federation, Spain, United Kingdom
Ferring Pharmaceuticals

Completed

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women

Controlled Ovarian Simulation

Korea, Republic of, Taiwan, China, Vietnam
Glycotope GmbH

Completed

Efficacy and Safety of FSH-GEX™ in Comparison With 150 IU Gonal-f®

Infertility

Germany, Hungary
Reproductive Specialists of New York

Completed

AMH and Dosing Regimens for Initial IVF Stimulation Protocols

Infertility
Merck KGaA, Darmstadt, Germany
Merck Serono GmbH, Germany

Completed

To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen

Infertility | Ovulation Induction
Ferring Pharmaceuticals

Completed

Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program

Infertility

China
Merck KGaA, Darmstadt, Germany
Merck Serono Middle East FZ-LLC, United Arab Emirates, an affiliate of Merck...

Completed

Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction

Ovulation Induction

Kuwait, Lebanon, Saudi Arabia
Glycotope GmbH
Glycotope Biotechnology GmbH

Completed

Single Dose FSH-GEX™ in Healthy Volunteers

Female Infertility

Netherlands
Merck KGaA, Darmstadt, Germany
Merck Ltd., Taiwan

Terminated

Predictive Factors of Ovarian Response in Ovulation Induction With Intrauterine Insemination of a Gonal-f Low-dose Regimen

Infertility

Taiwan
Merck KGaA, Darmstadt, Germany

Completed

A Study to Evaluate the Ease of Use, Local Tolerance, Safety and Effectiveness of Gonal-f® (Filled-by-mass in a Prefilled Pen)

Infertility

Greece
EMD Serono

Completed

A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction

Infertility
Merck KGaA, Darmstadt, Germany
Merck Serono GmbH, Germany; Merck B.V., Netherlands; Merck A.E., Greece; Merck... and other collaborators

Completed

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique (PERSIST)

Assisted Reproductive Techniques | Reproductive Technology, Assisted

Italy, Russian Federation, United Kingdom, Germany, Poland, Finland, Slovakia, Netherlands, Denmark, France, Greece
Ferring Pharmaceuticals

Completed

Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females (Compass)

Anovulation

China
Centre Hospitalier Chretien
EMD Serono

Withdrawn

Study of Optimal Posology of Gonadotrophins in Patients With Insufficient Ovarian Response Due to Age

Infertility

Belgium
Merck KGaA, Darmstadt, Germany

Completed

Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization (Prestyje)

Infertility | Ovulation Induction | In-Vitro Fertilization

Germany
Merck KGaA, Darmstadt, Germany

Completed

Lutropin Alfa in Women at Risk of Poor Response

Ovarian Stimulation

Spain
Qilu Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment

Infertility

China
Dong-A ST Co., Ltd.

Completed

A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®

Infertility | Anovulation

Korea, Republic of
Genesis Center for Fertility & Human Pre-Implantation...

Unknown

Recombinant Versus Highly Purified FSH in Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome

Cyprus
Reproductive & Genetic Hospital of CITIC-Xiangya

Recruiting

CLBR Per Initial Cycle With Different Starting Dose in Aged Patients With Poor Ovarian Reservation: 300IU Versus 150IU

Infertility

China
IVFarma LLC
Institute for Preventive and Social Medicine

Completed

An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data

Fertility Issues | Fertility Disorders | IVF | Gynecologic Disease | Reproductive Issues | Reproductive Disorder

Russian Federation
Azienda USL Modena
University of Roma La Sapienza; University of Padova; University of Florence; Istituto... and other collaborators

Completed

FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy

Male Infertility

Italy, Germany
Merck KGaA, Darmstadt, Germany

Completed

A Prospective, Multi-centric Observational Study to Determine the Mono-bifollicular Development in Infertile Women Subjected to Ovulation Induction With Follitropin α (P450)

Ovulation Induction

Spain
Merck KGaA, Darmstadt, Germany
Merck Pte. Ltd., Singapore

Completed

An Observational Study of Cetrotide® Gonadotropin-releasing Hormone Antagonist (GnRH Antagonist) With GONAL-f® in Assisted Reproductive Technologies (ART)

Infertility

Singapore
Ferring Pharmaceuticals

Recruiting

A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China (COCO)

Infertility, Female

China
University of California, San Diego

Active, not recruiting

Ovarian Reserve Testing in Female Young Adult Cancer Survivors

Cancer | Infertility

United States
Ferring Pharmaceuticals

Completed

A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

Infertility

Belgium, Denmark, Spain, Czechia
Merck KGaA, Darmstadt, Germany

Completed

Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)

Infertility

United States
Merck KGaA, Darmstadt, Germany

Completed

Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF) (CONSORT)

Infertility

France
Merck KGaA, Darmstadt, Germany

Completed

A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women

Infertility

Canada
U.O. Chirurgia Andrologica
Androcenter, Napoli, Italy

Unknown

Role of FSHR Polymorphism p.N680S in the Therapy With FSH in Patients Who Underwent Varicocele Surgery

Infertility, Male | Varicocele
Instituto Valenciano de Infertilidad, IVI VALENCIA

Not yet recruiting

Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA) (TROPIX)

Infertility, Female | Reproductive Sterility

Spain
GeneScience Pharmaceuticals Co., Ltd.
Peking University First Hospital; Peking University People's Hospital; Qilu Hospital... and other collaborators

Completed

Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation

Anovulation
Organon and Co

Completed

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)

Pregnancy | Neonates

3

Subscribe